KromaTiD lands grant to advance gene-analysis technology
FORT COLLINS — KromaTiD Inc. in Fort Collins has been awarded a Fast-Track Small Business Innovation Research grant by the National Human Genome Research Institute.
The grant, just shy of $1 million, will fund KromaTiD’s development of an automated platform capable of measuring complex structural variations in human genes.
KromaTiD currently has a manually operated system of analyzing genes. With that platform, KromaTiD provides commercial assays for detection of cancer-causing genes, discovery of disease-causing variants, measure biological responses to radiation, and measure structural off-target effects caused by gene-editing.
“Through this SBIR award, the NIH…
THIS ARTICLE IS FOR SUBSCRIBERS ONLY
Continue reading for less than $3 per week!
Get a month of award-winning local business news, trends and insights
Access award-winning content today!
Related Posts
-
Mindful Therapy Group of Colorado P.C., a national collaborative of mental health clinicians, will open…
-
The saga over a local memory care center potentially being taken over by its bank…
-
Enlitic Inc. (ASX:ENL), a health-care data analytics firm with operations in Fort Collins and Australia,…
-
Woodward Inc. (Nasdaq: WWD), a Fort Collins company that designs, manufactures and services energy-conversion and…
